Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected Individuals

Podobne zapisy

• Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
  od: Whelan, Kathryn T., i wsp.
  Wydane: (2009)
• Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
  od: Whelan, Kathryn T., i wsp.
  Wydane: (2011)
• Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
  od: Pathan, Ansar A., i wsp.
  Wydane: (2012)
• Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A
  od: Griffiths, Kristin L., i wsp.
  Wydane: (2011)
• Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG-Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A
  od: de Cassan, Simone C., i wsp.
  Wydane: (2010)